by David Bijnens
Anima Research Center in Alken will soon participate in a new study into improved antibody treatment against the corona virus. This extra shot, on top of the vaccine, should sufficiently protect the most vulnerable patients against the omikron variant of the covid virus: a world first. Anima Research Center will test the new antibody treatment on behalf of pharmaceutical company AstraZeneca. The research should yield the first results by the autumn. Then our country will start with the fifth vaccination campaign against the corona virus.
2023-06-28 16:30:00
#World #Alken #research #center #tests #improved #antibody #treatment #omikron #variant
Related posts:
There are already 'victims' in Asia, it turns out that this is what makes the deadly monkey pox
Trieste, at the Oberdan 27 centini ready for university: it is the Medicine test that stands out amo...
German Federal Government Spent Almost 440 Billion Euros to Combat Corona Pandemic in Three Years
Back to the week of health and old age professions
